4//SEC Filing
Yablonka Uri 4
Accession 0001104659-25-000892
CIK 0001137883other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:34 PM ET
Size
7.7 KB
Accession
0001104659-25-000892
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2025-01-01+20,000→ 68,464 total - Award
Common Stock
2025-01-01+40,000→ 48,464 total
Footnotes (3)
- [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan (the "Plan"). The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
- [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.
- [F3]Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001608814
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:34 PM ET
- Size
- 7.7 KB